申请人:Laboratoire L. Lafon
公开号:US04122186A1
公开(公告)日:1978-10-24
The invention provides new acetohydroxamic acid derivatives, having interesting properties on the central nervous system, of the formula: R.sub.1 R.sub.2 R.sub.3 C-CO-NHOH, in which R.sub.2 and R.sub.3 are each hydrogen or C.sub.1-6 alkyl, and R.sub.1 is C.sub.1-6 alkyl Z.sub.1 Z.sub.2 N (where Z.sub.1 and Z.sub.2 are each phenyl, substituted phenyl, or cycloalkyl), substituted hydantoinyl, benzhydroxylcarboxamido, Z.sub.3 CH.sub.2 -- (where Z.sub.3 = optionally substituted aryl), Z.sub.4 -A- (where Z.sub.4 is optionally substituted phenyl or naphthyl, and A is --NH--, --N(C.sub.1-4 alkyl)--, --N(C.sub.5-6 cycloalkyl)--, --NHCO--, --N(C.sub.1-4 alkyl)CO--, --N(C.sub.5-6 cycloalkyl)CO--, --CONH--, --CON(C.sub.1-4 alkyl)--, --CON(C.sub.5-6 cycloalkyl)--, --NHCONH--, --N(C.sub.5 H.sub.6)CONH--, or --N(substituted phenyl)CONH--, optionally substituted benzimidazolyl, or an optionally substituted tricyclic radical, and their metal and acid addition salts.
该发明提供了新的乙酰羟羟胺酸衍生物,具有对中枢神经系统有趣的性质,其化学式为:R.sub.1 R.sub.2 R.sub.3 C-CO-NHOH,其中R.sub.2和R.sub.3分别为氢或C.sub.1-6烷基,R.sub.1为C.sub.1-6烷基Z.sub.1 Z.sub.2 N(其中Z.sub.1和Z.sub.2分别为苯基、取代苯基或环烷基)、取代咪唑烷基、苯羟基羧酰胺基、Z.sub.3 CH.sub.2-(其中Z.sub.3=可选择取代芳基)、Z.sub.4-A-(其中Z.sub.4为可选择取代苯基或萘基,A为--NH--、--N(C.sub.1-4烷基)--、--N(C.sub.5-6环烷基)--、--NHCO--、--N(C.sub.1-4烷基)CO--、--N(C.sub.5-6环烷基)CO--、--CONH--、--CON(C.sub.1-4烷基)--、--CON(C.sub.5-6环烷基)--、--NHCONH--、--N(C.sub.5 H.sub.6)CONH--或--N(取代苯基)CONH--、可选择取代苯并咪唑基或可选择取代三环基,以及它们的金属和酸盐。